c-Fms-CSF-1R Antibodies

Santa Cruz Biotechnology features a diverse variety of c-Fms-CSF-1R monoclonal antibodies for investigating colony-stimulating factor 1 receptor (CSF-1R) in various biological processes. The monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CSF-1R is a critical receptor involved in the regulation of monocyte and macrophage differentiation, survival, and function. CSF-1R signaling plays a significant role in immune responses, tissue homeostasis, and inflammation. Dysregulation of CSF-1R signaling has been implicated in various diseases, including cancer and autoimmune disorders, making it an important target for therapeutic intervention. Understanding CSF-1R function and regulation is essential for developing new therapeutic strategies. Investigating CSF-1R pathways can reveal crucial insights into immune system modulation and disease progression. Research utilizing c-Fms-CSF-1R monoclonal antibodies contributes significantly to advancing scientific knowledge in immunology and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of CSF-1R biology and its potential therapeutic applications.